A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2

A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2

Abstract The ongoing SARS‐CoV‐2 pandemic stresses the need for effective antiviral drugs that can quickly be applied in order to reduce morbidity, mortality, and ideally viral transmission. By repurposing of broadly active antiviral drugs and compounds that are known to inhibit viral replication of...

Full description

Bibliographic Details
Main Authors: Alexander Simonis, Sebastian J Theobald, Gerd Fätkenheuer, Jan Rybniker, Jakob J Malin
Format: Article
Language:English
Published: Springer Nature 2021-01-01
Series:EMBO Molecular Medicine
Subjects:
antivirals
COVID‐19
remdesivir
SARS‐CoV‐2
Online Access:https://doi.org/10.15252/emmm.202013105

Similar Items

Similar Items